相关实验视频
Updated: Sep 20, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.9K
在所有严重程度的喘中表征保留比率受损螺旋法表型
Marcello Cottini1, Remo Poto2, Atanu Bhattacharjee3
1Allergy and Pneumology Outpatient Clinic, Bergamo, Italy.
Respiratory medicine
|May 29, 2025
概括
维护比率受损螺旋计 (PRISm) 喘表型与更频繁的恶化和更糟糕的症状控制有关. 这凸显了识别PRISm对于更好的喘管理的重要性.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 保存比率受损螺旋计 (PRISm) 现型,定义为正常FEV1/FVC比率,但减少FEV1,在喘中越来越多地被识别出来.
- 小气道功能障碍 (SAD) 在喘中普遍存在,并与不良的临床结果相关,可通过振荡计测量.
- 了解PRISm的流行率和临床影响对于有效的喘管理至关重要.
研究的目的:
- 确定患有持续性喘的成年人中PRISm表型的流行率.
- 研究PRISM与小气道功能障碍 (SAD) 之间的关联.
- 评估PRISm与喘恶化率和症状控制之间的关系.
主要方法:
- 来自GINA定义的持续性喘的937名成年人的数据的回顾性分析.
- 利用多变量逻辑回归来评估PRISm与恶化频率和症状控制之间的关联.
- 包括振荡计参数 (Rrs5-20,X5,AX) 来评估SAD.
主要成果:
- 在中度至重度喘患者中, Prism 存在于 19.6% 的患者中.
- PRISm与经历一次或多次恶化 (OR 3.00) 和两次或多次恶化 (OR 4.00) 的更高可能性显著相关.
- 与呼吸道阻塞患者相比,PRISm患者出现了不受控制的症状 (OR 14.04),并处方了较低的吸入性皮质类固醇 (ICS) 剂量.
结论:
- PRISm喘表型与恶化频率增加和症状控制较差有关.
- 与正常螺旋计相比,PRISm与小气道功能障碍 (SAD) 的更高患病率有关.
- 需要进一步的纵向研究来确认PRISm的进展,并探索治疗干预措施.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:20Asthma: Pathogenesis and Management
623
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
623
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K